Institutional Sign In

Go

Sanofi-Aventis Czech Republic - Net Profit Growth

Sanofi-Aventis CR`s Net Profit Growth reached -58.8 % in 2017. This is 59.6 % more than in the previous year.

$1.99

Buy Net Profit Growth data for Sanofi-Aventis Czech Republic.

$19.99

Buy all data for Sanofi-Aventis Czech Republic.

from $199/month

Buy annual subscriptions for all our products.

 
Company Unit 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017
Amgen Czech Republic % ... ... ... ... ...           57.1 -38.7 1.42 40.8 -11.4    
Bayer Czech Republic % ... ... ...               39.4 -49.7 15.3 11.2 15.4    
GlaxoSmithKline Czech Republic % ... ... ...               45.3 -31.8 -22.2 -31.2 42.1    
Merck Czech Republic % ... ...                 321 28.7 -56.9 27.5 96.7    
Novartis Czech Republic %                     0.860 19.7 4.60 57.3 0.548    
Pfizer Czech Republic % ... ...                 137 -79.2 200 -7.25 -43.7    
Roche Czech Republic % ... ... ...               -50.1 -23.3 248 -29.6 -46.3   ...
Sanofi-Aventis Czech Republic % ... ... ... ...             18.2 -17.9 44.2 -98.2 4,839    
Servier Czech Republic % ... ... ... ... ... ... ... ... ... ... ... ... 5.92 0.125 16.7    
Walmark % ... ... ...               63.4 -101 187 -585 -1,813